In this large randomized trial of 600 patients with severe sepsis/shock, meropenem alone performed just as well as the combination of meropenem + moxifloxacin for organ failure and mortality. In this scenario, the addition of moxifloxacin was of no benefit (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.